Care UK acquired by Welltower

UNITED KINGDOM Health Providers / Healthcare Facilities / Nursing Homes REV £250–500M

Context

Bridgepoint divested its entire stake in Care UK to Welltower, a US healthcare REIT, marking the conclusion of approximately 14 years of private equity ownership. Bridgepoint had originally acquired Care UK in 2010 and had previously attempted an unsuccessful sale process, incurring £2.5 million in abortive advisory costs as disclosed in its 2019 accounts. The deal excludes Practice Plus Group, which was carved out by Bridgepoint in 2019 and remains under its ownership. Bridgepoint was advised by Barclays (corporate finance), Allen & Overy (legal), and EY (financial and tax).

It is worth noting that the fund Bridgepoint took control of Care UK through an LBO in 2010.

Care UK, which reported an EBITDA margin of [members only] in 2023, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average observed in the Healthcare & Pharma sector (15.6x in 2024).

-> Deep-dive in Healthcare & Pharma market trends

Target

Care UK is one of the UK's largest residential care home chains, founded in 1982 and operating more than 150 homes for older people across the United Kingdom, employing approximately 10,500 staff. Under Bridgepoint's ownership since 2010, the business more than doubled its estate from 59 homes at entry, and fundamentally transformed its revenue mix by increasing the proportion of higher-margin private-pay residents from 5% to over 50%. Care UK is widely recognised as a market leader in care quality, holding the highest number of Outstanding-rated homes in England as assessed by the Care Quality Commission, and achieving 100% compliance in Scotland and Wales.

Ent. Value

[members only]

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (GBP)

Year

Rev

EBITDA

EBIT

2023

2022

Other operations with Care UK

Other operations with Care UK
Date	Acquirer	Target	Country	Sector
03/2010	BRIDGEPOINT	CARE UK	UNITED KINGDOM	Nursing Homes

Similar deals in Health Providers

Similar deals in Health Providers
Date	Acquirer	Target	Country	Sector
12/2024	CAPZA	IMDEV	FRANCE	Radiology
12/2024	SONIC HEALTHCARE	LADR – LABORATORY GROUP DR. KRAMER & COLLEAGUES	GERMANY	Labs (Biology)
11/2024	GROUPE IMAGERIE CARDINET	RADIOLOGIE PARIS OUEST	FRANCE	Radiology
10/2024	QUALIUM	IMPC (IMAGERIE MEDICALE PARIS CENTRE)	FRANCE	Radiology
10/2024	ARDIAN	VISTA VISION	ITALY	Ophthalmology
10/2024	MONTEFIORE INVESTMENT	DEMENEGO	ITALY	Ophthalmology
08/2024	ORLANDO HEALTH	BROOKWOOD BAPTIST HEALTH SERVICES	UNITED STATES	Clinics / Hospitals
06/2024	L-GAM / CAPZA / IDIA CAPITAL INVESTISSEMENT	PSV GROUP	FRANCE	Radiology
06/2024	INTEGRAL DIAGNOSTICS LIMITED	CAPITOL HEALTH LIMITED	AUSTRALIA	Radiology
01/2024	ARDIAN / BPIFRANCE / MACSF	APRIUM PHARMACIE	FRANCE	Pharmacy

REFERENCES

Revenue range: REV £250–500M

EBITDA range: £50–100M

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Care UK by Welltower are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers Welltower’s acquisition of 100% of Care UK, a British company specialised in Healthcare Facilities, in 2024. This followed an earlier holding cycle initiated in March 2010, when the company was acquired by Bridgepoint.

What were Care UK’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Care UK generated annual revenue estimated in the £250–500M range and EBITDA in the £50–100M bracket (FY 2023). Detailed financial figures are available to members.

How does the valuation of Care UK compare to benchmarks in the Healthcare & Pharma sector?

Transaction multiples for this specific deal are exclusively reserved for mynth members. Nevertheless, transactions tracked by mynth in this sector reveal an average benchmark multiple of 15.6x EBITDA during 2024.

What sources support the information on this transaction?

Data on this transaction was compiled from the official corporate announcement published by the parties, combined with independent reporting from specialized financial and M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.